Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review

The incidence of in situ melanoma (MIS) has increased over the last decades. The mainstay of treatment for MIS, including lentigo maligna (LM), is complete surgical excision with clear margins (0.5 to 1.0 cm). Nevertheless, MIS lesions often affect elderly patients with comorbidities and involve lar...

Full description

Bibliographic Details
Main Authors: Sandra Martínez-Fernández, Beatriz González-Sixto, Martina Espasandín-Arias, Diego Soto-García, Ángeles Flórez
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/18/4468